_{LATEST HIGHLIGHT:}

Volunteers needed for trial of newly developed
vaccine candidate for respiratory diseases

AIBN is solving serious problems in health, energy and the bioeconomy
using advanced biomanufacturing, precision nanomedicine and nanoengineered materials.

Our research teams are working with industry and governments to make critical strides forward and impacts in areas that include: mRNA manufacturing and vaccine development, diagnostics to discover and treat diseases, future foods and biosustainability projects reprograming cells to help the world’s biggest companies transition to net zero.

Learn more about AIBN

Part of Australia's
#1 University
500+ world-class researchers
9 co-located NCRIS Facilities

Over $250m in research revenue
100+ industry partnerships
22% of UQ’s patent portfolio is generated by the AIBN

Organoids: Tiny organs shaping modern medicine

AIBN researchers are using organoids to transform our approach to addressing the world’s most serious health problems.
ViceBio and the Rapid Response Vaccine Pipeline

The AIBN has the knowledge and infrastructure to ensure Australia can develop and deliver clinical-grade vaccines whenever, and wherever, they are needed.
Chemical capture: Remediating contamination with new materials

Developing new, cost effective technologies to remediate and protect remote sites and waterways that have been contaminated ‘forever chemicals’ (PFAS).